Temperature control method and device for producing chitosan nonwoven fabrics

By analyzing and optimizing the target performance of chitosan nonwovens, identifying the influence of temperature control and applying the excellence and Nash balance algorithm, the problem that temperature control is difficult to balance physical and chemical sustained release performance in chitosan nonwovens production is solved. , achieving improvement in product performance and meeting market demand.

CN118534953BActive Publication Date: 2024-11-01NANTONG TONGZHOU JIANGHUA TEXTILE CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410996535.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-07-24
Publication Date
2024-11-01
Estimated Expiration
2044-07-24

AI Technical Summary

Technical Problem

The prior art is difficult to accurately and comprehensively balance the physical properties and the sustained release properties of the agent in the production of chitosan non-woven fabrics, resulting in the inability to meet expectations and the diversified market needs.

Method used

By obtaining the target performance of non-woven fabrics, analyzing the relevant performance response variables and configuring the proportion coefficients, identifying the correlation between crosslinking temperature and control time, filtering performance response variables that meet the threshold as control performance targets, and using the optimization algorithm and Nash The equalization algorithm optimizes the temperature control strategy to achieve a balance between physical performance and drug sustained release performance.

Benefits of technology

It improves the overall quality and performance of the product and meets the market's technical effect of diversified performance requirements of chitosan non-woven fabrics.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118534953B_ABST
    Figure CN118534953B_ABST
Patent Text Reader

Abstract

The present invention discloses a temperature control method and device for the production of chitosan non-woven fabrics, and relates to fields related to material processing technology. The method includes: obtaining target performance such as physical properties and sustained-release performance of non-woven fabrics, analyzing relevant performance response variables and configuring proportion coefficients, identifying the correlation and determining the influence degree with cross-linking temperature and control time as targets, and when the control performance target includes physical and sustained-release performance of pharmaceutical agents, using its response variables as optimization variables to obtain the first and second temperature control strategies through an optimization algorithm, and then optimizing with a Nash equilibrium algorithm based on the reset coefficient to obtain a production line temperature control strategy. The technical problem that the prior art cannot accurately and comprehensively balance the temperature control requirements of physical properties and sustained-release performance of pharmaceutical agents in the production of chitosan non-woven fabrics, and cannot formulate a scientific, optimized, and adaptable temperature control strategy is solved, and the technical effect of improving the overall quality and performance of the product and meeting the diversified needs of the market is achieved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the technical field of material processing, and in particular to a temperature control method and device for producing chitosan nonwoven fabrics. Background Art

[0002] In the production scenario of chitosan non-woven fabrics, the problem of balancing the physical properties and the sustained-release properties of pharmaceuticals is particularly prominent, and the contradiction between the demand for efficient and accurate temperature control is relatively more prominent. Scientific optimization of temperature control strategies and better realization of the ideal balance between the two properties have become a crucial link in the production of chitosan non-woven fabrics. The temperature control in the traditional production of chitosan non-woven fabrics is often extensive and one-sided, relying only on simple empirical judgments or limited experimental data. There is a lack of comprehensive and in-depth analysis and utilization of the temperature impact in the production process, and it is difficult to accurately determine the optimal temperature conditions under different performance requirements. In the formulation of temperature control strategies, there are unscientific and unreasonable situations, which lead to product performance failing to meet expectations and failing to meet the market's diverse performance requirements for chitosan non-woven fabrics.

[0003] At present, relevant technologies have the technical problem that the temperature control requirements for the physical properties and sustained-release performance of the drug cannot be accurately and comprehensively balanced in the production of chitosan non-woven fabrics, and a scientific, optimized and adaptable temperature control strategy cannot be formulated. Summary of the invention

[0004] The present application provides a temperature control method and device for the production of chitosan non-woven fabrics, which obtains target performance such as the physical properties and drug sustained-release performance of the non-woven fabrics, analyzes relevant performance response variables and configures proportion coefficients, identifies the correlation and determines the influence degree with the cross-linking temperature and control time as the target, screens the performance response variables that meet the threshold as the control performance target and resets the proportion coefficient. When the control performance target includes physical and drug sustained-release performance, the response variables are used as optimization variables through the first and second temperature control strategies of the optimization algorithm, and then optimized with the Nash equilibrium algorithm based on the reset coefficient to obtain the production line temperature control strategy, thereby achieving the technical effect of improving the overall quality and performance of the product and meeting the diversified market needs.

[0005] The present application provides a temperature control method for producing chitosan nonwoven fabrics, comprising:

[0006] Obtain the target performance of the non-woven fabric, including physical properties and drug sustained-release performance; based on the target requirements of the physical properties and drug sustained-release performance, analyze the performance response variables, the performance response variables are descriptive parameter variables related to the physical properties and drug sustained-release performance, and configure the proportion coefficient of each performance response variable according to the target requirements; take the cross-linking temperature and temperature control time as the target, identify the correlation of the performance response variables, and determine the temperature control influence; select the performance response variables whose temperature control influence meets the threshold as the control performance target, and reset the proportion based on the proportion coefficient to obtain the control performance reset coefficient; when the control performance target includes the physical properties and drug sustained-release performance, respectively use the performance response variables of the physical properties and drug sustained-release performance as optimization variables, and obtain the first temperature control strategy and the second temperature control strategy through the optimization algorithm, the first temperature control strategy corresponds to the physical properties, and the second temperature control strategy corresponds to the drug sustained-release performance; based on the control performance reset coefficient, use the Nash equilibrium algorithm to balance and optimize the first temperature control strategy and the second temperature control strategy to obtain the production line temperature control strategy.

[0007] The present application also provides a temperature control device for the production of chitosan nonwoven fabrics, comprising:

[0008] A target performance acquisition module, the target performance acquisition module is used to obtain the target performance of the non-woven fabric, including physical properties and drug sustained-release performance; a proportion coefficient configuration module, the proportion coefficient configuration module is used to parse the performance response variables based on the target requirements of the physical properties and drug sustained-release performance, the performance response variables are descriptive parameter variables related to the physical properties and drug sustained-release performance, and the proportion coefficients of each performance response variable are configured according to the target requirements; a temperature control influence determination module, the temperature control influence determination module is used to identify the correlation of the performance response variables with the cross-linking temperature and the temperature control time as the target, and determine the temperature control influence; a coefficient reset module, the coefficient reset module is used to screen the performance response variables whose temperature control influence meets the threshold as the control The control performance target is set, and the proportion is reset based on the proportion coefficient to obtain the control performance reset coefficient; a control strategy acquisition module, wherein the control strategy acquisition module is used to, when the control performance target includes the physical property and the sustained-release performance of the drug, use the performance response variables of the physical property and the sustained-release performance of the drug as optimization variables, and obtain the first temperature control strategy and the second temperature control strategy through an optimization algorithm, wherein the first temperature control strategy corresponds to the physical property, and the second temperature control strategy corresponds to the sustained-release performance of the drug; a production line temperature control strategy acquisition module, wherein the production line temperature control strategy acquisition module is used to optimize the first temperature control strategy and the second temperature control strategy based on the control performance reset coefficient using a Nash equilibrium algorithm to obtain a production line temperature control strategy.

[0009] The temperature control method and device for the production of chitosan non-woven fabrics proposed in this application are intended to first obtain the target properties such as the physical properties and drug sustained-release properties of the non-woven fabric, parse the relevant performance response variables and configure the proportion coefficient, identify the correlation and determine the influence degree with the cross-linking temperature and control time as the target, screen the performance response variables that meet the threshold as the control performance target and reset the proportion coefficient, when the control performance target includes physical and drug sustained-release properties, use its response variables as optimization variables through the first and second temperature control strategies of the optimization algorithm, and then optimize with the Nash equilibrium algorithm based on the reset coefficient to obtain the production line temperature control strategy, thereby achieving the technical effect of improving the overall quality and performance of the product and meeting the diversified needs of the market. BRIEF DESCRIPTION OF THE DRAWINGS

[0010] In order to more clearly illustrate the technical solution of the embodiment of the present invention, the accompanying drawings of the embodiment of the present invention will be briefly introduced below. A flow chart is used in the present application to illustrate the operations performed by the device according to the embodiment of the present application. It should be understood that the previous or following operations are not necessarily performed precisely in order. On the contrary, various steps can be processed in reverse order or simultaneously as needed. At the same time, other operations can also be added to these processes, or one or more operations can be removed from these processes.

[0011] Figure 1 A schematic flow chart of a temperature control method for producing chitosan nonwoven fabrics provided in an embodiment of the present application;

[0012] Figure 2 This is a schematic structural diagram of a temperature control device for producing chitosan non-woven fabrics provided in an embodiment of the present application.

[0013] Explanation of the reference numerals: target performance acquisition module 10 , proportion coefficient configuration module 20 , temperature control influence determination module 30 , coefficient reset module 40 , control strategy acquisition module 50 , production line temperature control strategy acquisition module 60 . DETAILED DESCRIPTION

[0014] The above description is only an overview of the technical solution of the present application. In order to more clearly understand the technical means of the present application, it can be implemented in accordance with the contents of the specification. In order to make the above and other purposes, features and advantages of the present application more obvious and easy to understand, the specific implementation methods of the present application are listed below.

[0015] In order to make the purpose, technical solutions and advantages of the present application clearer, the present application will be further described in detail below in conjunction with the accompanying drawings. The described embodiments should not be regarded as limiting the present application. All other embodiments obtained by ordinary technicians in the field without making creative work are within the scope of protection of this application.

[0016] In the following description, reference is made to "some embodiments", which describe a subset of all possible embodiments, but it is understood that "some embodiments" may be the same subset or different subsets of all possible embodiments, and may be combined with each other without conflict, and the terms "first\second" involved are merely to distinguish similar objects and do not represent a specific ordering of objects. The terms "including" and "having" and any variations are intended to cover non-exclusive inclusions, for example, a process, method, device, product, or server that includes a series of steps or units is not necessarily limited to those steps or units clearly listed, but may include other steps or modules that are not clearly listed or inherent to these processes, methods, products, or devices. Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those generally understood by technicians in the technical field of this application. The terms used herein are for the purpose of describing the embodiments of the present application only.

[0017] The present application embodiment provides a temperature control method for producing chitosan nonwoven fabrics, such as Figure 1 As shown, the method includes:

[0018] Step S100, obtaining the target performance of the non-woven fabric, including physical properties and drug sustained-release performance. Specifically, the target performance of the non-woven fabric is obtained, including physical properties and drug sustained-release performance. Select the direction of target performance analysis, prepare relevant tools for performance testing, set specific indicators for performance analysis, such as strength index, flexibility index, air permeability index in physical performance, sustained-release time index, release rate index, release amount index, etc. in drug sustained-release performance, perform performance analysis operation, obtain preliminary data of physical performance, physical performance data represents the performance of non-woven fabric in terms of strength, flexibility, etc., and its characteristics are to reflect the degree of physical performance, continue to perform performance analysis, obtain drug sustained-release performance data, drug sustained-release performance data represents the process and effect of drug release from non-woven fabric under specific conditions, and its characteristics are to reflect the quality of drug sustained-release performance, clarify the application scenarios and final uses of non-woven fabrics, such as wound dressings in the medical field, facial masks in the beauty field, or food packaging, etc., different application scenarios will have different emphases on the performance of non-woven fabrics.

[0019] In a possible implementation, the target performance of the nonwoven fabric, including physical properties and sustained-release performance of the drug, is obtained, and step S100 further includes step S110, obtaining user performance requirements. Specifically, the user performance requirements are obtained through a variety of channels and methods, including face-to-face communication with users, issuing detailed questionnaires, analyzing users' past purchase and use records, or organizing focus group discussions, etc., to collect users' expectations and specific requirements for the physical properties of nonwoven fabrics and sustained-release performance of drugs as comprehensively and accurately as possible.

[0020] Step S120, setting performance indicators according to the physical properties and sustained-release performance of the drug. Specifically, specific and quantifiable performance indicators are set according to the determined physical properties (such as strength, air permeability, softness, etc.) and sustained-release performance of the drug (such as sustained-release time, release rate, total release amount, etc.). When setting the physical performance indicators, it is necessary to refer to the performance data of industry standards and similar products, and to determine the specific numerical range or level in combination with user needs. For example, for strength, it may be set to be able to withstand a certain tensile force without breaking; for softness, it is set to meet a specific touch standard. For sustained-release performance indicators of the drug, it should be set according to the application field and the characteristics of the drug. For example, for drug release, it is set to reach a certain release amount within a specific time; for the release of essence in the mask, it is set to be released evenly within a certain time and maintain a certain residual amount to ensure the effect.

[0021] Step S130, construct cluster features according to the performance indicators, and perform feature analysis on the user performance requirements to determine the user demand feature vector. Specifically, cluster features are constructed according to the performance indicators. For example, for strength, the performance that can withstand a certain range of tension is classified as a feature; for softness, the degree of softness in a specific range is classified as a feature; for air permeability, the air permeability reaching a certain level is classified as a feature. For the sustained release performance of the drug, the release rate and the total release amount within a specific range are classified as a feature, and the user performance requirements are analyzed to determine the user demand feature vector. A certain weight is assigned to each performance indicator, such as a higher weight for strength, moderate weights for softness and air permeability, and the weight of the sustained release performance of the drug is set according to its importance. Through quantification and weighted processing of user needs, the demand feature vector of each user is obtained.

[0022] Step S140, clustering is performed using the user demand feature vector and the clustering feature to obtain the target features of the physical properties and the target features of the sustained-release performance of the drug, and to construct the target performance of the non-woven fabric. Specifically, clustering is performed using these user demand feature vectors and clustering features to group users with similar demand features into one category. In the clustering process, the target features of the physical properties and the target features of the sustained-release performance of the drug are obtained. For example, the physical performance features of a certain type of user are that the strength is at a high level, and the softness and breathability are within a specific range; the sustained-release performance features of the drug are that the release rate and the total release amount meet certain standards. The target features of the physical properties and sustained-release performance of the drug are obtained comprehensively to construct the target performance of the non-woven fabric. The final target performance of the non-woven fabric is determined based on the proportion and importance of each type of user, and the needs of the user groups that account for a large proportion and are important are given priority.

[0023] Step S200, based on the target requirements of the physical properties and the sustained-release performance of the drug, the performance response variables are parsed, and the performance response variables are descriptive parameter variables related to the physical properties and the sustained-release performance of the drug, and the proportion coefficients of the performance response variables are configured according to the target requirements. Specifically, the target requirements of the physical properties and the sustained-release performance of the drug are clarified, and the performance response variables related to the target requirements are parsed. For physical properties, the performance response variable of strength may be the fiber strength and weaving density of the material; the response variable of softness may be the material of the fiber, the thickness of the fiber, etc.; the response variable of air permeability may be the pore size and pore distribution of the non-woven fabric, etc. For the sustained-release performance of the drug, the response variable of the release rate may include the characteristics of the drug's wrapping material, the thickness of the wrapping layer, etc., and the response variable of the total release amount may involve the loading amount of the drug, the release mechanism, etc. The proportion coefficients of each performance response variable are configured according to the target requirements. For the sustained-release performance of the drug, the proportion coefficients of each performance response variable are determined, so as to provide a clear direction and basis for subsequent product design and improvement.

[0024] In a possible implementation, based on the target requirements of the physical properties and sustained-release performance of the drug, the performance response variables are parsed, the performance response variables are descriptive parameter variables related to the physical properties and sustained-release performance of the drug, and the proportion coefficients of the performance response variables are configured according to the target requirements. Step S200 further includes step S210, determining the target requirements according to the user performance requirements, and quantifying the target requirements. Specifically, the user performance requirements are clarified and converted into target requirements, and then quantified. For example, the user hopes that the strength of the non-woven fabric is higher, which is quantified as a strength of not less than 180N; the user hopes that the softness is moderate, which is quantified as a softness between 60 and 80 (assuming that 0 is the hardest and 100 is the softest); and the user requires good air permeability, which is quantified as an air permeability of more than 700 ml per minute. For the sustained-release performance of the drug, for example, it is hoped that the drug release rate is between 25% and 35% within the first 2 hours, and the total release amount reaches more than 85%.

[0025] Step S220, based on the quantitative requirements of the target demand, matching and analyzing the historical experimental data, determine the constraint proportion and impact adjustment coefficient of the performance response variable. Specifically, based on the quantified target demand, search and analyze the historical experimental data for matching and analysis. Taking strength as an example, the historical experimental data shows that factors such as fiber material, weaving method, and fiber density have different degrees of influence on strength. The influence of fiber material is relatively small, the influence of weaving method is medium, and the influence of fiber density is large. The constraint proportion of the performance response variable is determined.

[0026] Step S230, taking the constraint proportion as the basic proportion relationship, and distributing the proportion according to the quantitative requirements of the target demand according to the impact adjustment coefficient, determine the proportion coefficient, which is the weighted result of the basic proportion and the distribution proportion. Specifically, the proportion is adjusted according to the quantitative requirements of the target demand according to the magnitude of the impact. For example, since the fiber density has a greater impact on the strength, its proportion in achieving the strength target is appropriately increased; while the fiber material has a relatively small impact, its proportion is reduced, and finally the proportion coefficient is determined, and the final proportion coefficient is calculated by weight. For example, the final proportion coefficient of the fiber material is the basic proportion multiplied by its weight plus the adjusted distribution proportion multiplied by its weight. The proportion coefficient of each performance response variable is reasonably determined to optimize the performance of the non-woven fabric to meet user needs.

[0027] Step S300, with cross-linking temperature and temperature control time as the target, identify the correlation of the performance response variables and determine the temperature control influence. Specifically, determine the research scope of cross-linking temperature and temperature control time, conduct experiments, select different combinations of cross-linking temperature and temperature control time, evaluate and analyze the results obtained from each experiment, and the evaluation index is the performance of the product, such as strength, stability, etc. Assuming that the product strength is used as the evaluation index, the product strength in experiment 1 is 50N, the product strength in experiment 2 is 70N, and the product strength in experiment 3 is 80N. By comparing different experimental results, identify the correlation between performance response variables (cross-linking temperature and temperature control time). When the cross-linking temperature increases and the temperature control time is extended, the product strength will increase. In order to determine the temperature control influence, the change in product performance under different temperature control times can be calculated to more accurately determine the temperature control influence, thereby providing a basis for optimizing process parameters.

[0028] Step S400, the performance response variables whose temperature control influences meet the threshold are screened as control performance targets, and the proportion is reset based on the proportion coefficient to obtain the control performance reset coefficient. Specifically, the temperature control influences under different cross-linking temperatures and temperature control time combinations are determined, a threshold is set, and each calculated temperature control influence is screened. If a certain temperature control influence is greater than or equal to the threshold, the corresponding performance response variable (such as a specific combination of cross-linking temperature and temperature control time) is screened as a control performance target. Based on the screened control performance target, the proportion coefficient is reset. For example, the screened control performance target corresponds to a higher cross-linking temperature and a longer temperature control time, and its impact on product performance is more significant. If the screened control performance target shows that the impact of temperature control time is particularly prominent, the proportion of temperature control time is increased, and the proportion of cross-linking temperature is reduced. Through screening and proportion resetting, the factors that have an important impact on product performance can be more prominent, thereby obtaining a more optimized control performance reset coefficient to better guide the production process and improve product quality and performance.

[0029] In a possible implementation, the performance response variables whose temperature control influence meets the threshold are screened as control performance targets, and the proportion is reset based on the proportion coefficient to obtain the control performance reset coefficient. Step S400 further includes step S410, performing difference matching on the performance response variables according to the control performance target, and locating the difference adjustment performance variables. Specifically, the control performance target is determined, and the control performance target is differentially matched with the existing performance response variables, and the performance response variables include material composition ratio, processing temperature, processing time, etc., and the adjustment performance variables that cause the difference are located.

[0030] Step S420: When the difference adjustment performance variables exist, the adjustment proportion is extracted. Specifically, when the difference adjustment performance variables exist, the adjustment proportion currently occupied by the variables is extracted.

[0031] Step S430, obtaining the proportion coefficient of the control performance target, and using the proportion coefficient to calculate the proportional relationship. Specifically, the proportion coefficient set for each relevant performance variable in the control performance target is obtained, and the proportion coefficient is used to calculate the proportional relationship with the current actual proportion. For example, if the proportion coefficient of a certain performance variable in the control performance target is high, and the current actual proportion is relatively low, a certain proportion difference will be formed.

[0032] Step S440, redistribute the adjustment proportions using the proportional relationship to obtain a redistributed proportion. Specifically, based on the calculated proportional relationship, redistribute the previously extracted adjustment proportions to determine the redistributed proportion that each difference adjustment performance variable should obtain after redistribution.

[0033] Step S450, the control performance reset coefficient is obtained by superimposing the proportion coefficient of the control performance target and the redistribution proportion. Specifically, the proportion coefficient originally set in the control performance target is superimposed with the redistribution proportion obtained by redistribution, so as to obtain the final control performance reset coefficient. By resetting the coefficient, the proportion of each performance variable can be more reasonably adjusted to achieve the desired control performance target.

[0034] Step S500, when the control performance target includes the physical properties and the sustained-release performance of the drug, the performance response variables of the physical properties and the sustained-release performance of the drug are respectively used as optimization variables, and the first temperature control strategy and the second temperature control strategy are obtained through the optimization algorithm, wherein the first temperature control strategy corresponds to the physical properties, and the second temperature control strategy corresponds to the sustained-release performance of the drug. Specifically, it is clear that the control performance target includes physical properties (such as strength, softness, air permeability, etc.) and sustained-release performance of the drug (such as release rate, release amount, etc.). For physical properties, the related performance response variables (such as material properties related to strength, processing parameters, etc.) are used as optimization variables, and for sustained-release performance of the drug, the corresponding performance response variables (such as the type of drug, packaging material properties, etc.) are also used as optimization variables, and the optimization algorithm is used to process the optimization variables, and the optimization algorithm can be a simulated annealing algorithm, a genetic algorithm, etc. Assume that we use the simulated annealing algorithm to continuously try different combinations of variables and calculate the performance of each combination. For the optimization of physical properties, the algorithm will continuously change the value combination of the optimization variables related to the physical properties, and judge the pros and cons of each combination according to the pre-set evaluation criteria, such as whether the strength reaches a specific value, whether the softness is within the expected range, etc. After multiple iterations and screening, the variable combination that can achieve the best physical properties is finally determined, thereby obtaining the corresponding first temperature control strategy. For the optimization of the sustained-release performance of the drug, the optimization algorithm will perform similar operations on the optimization variables of the sustained-release performance of the drug, and continuously adjust the values ​​of the variables related to the drug, such as changing the thickness of the drug wrapping material, adjusting the concentration of the drug, etc., and judge the effect of each combination according to the evaluation criteria of the sustained-release performance of the drug, such as whether the release rate meets the requirements and whether the release amount meets the expectations. After repeated attempts and optimization, a variable combination that can achieve the ideal sustained-release performance of the drug is obtained, that is, the second temperature control strategy. By performing optimization calculations on the performance response variables of the physical properties and the sustained-release performance of the drug, the corresponding temperature control strategies are obtained to achieve the overall control performance goals.

[0035] Step S600, based on the control performance reset coefficient, the first temperature control strategy and the second temperature control strategy are optimized by using the Nash equilibrium algorithm to obtain the production line temperature control strategy. Specifically, the control performance reset coefficient has been obtained, and the coefficient reflects the importance and direction of the adjustment of the performance response variable. The first temperature control strategy (corresponding to the physical performance) and the second temperature control strategy (corresponding to the sustained-release performance of the drug) are used as inputs, and the Nash equilibrium algorithm is introduced for processing. The core idea of ​​the Nash equilibrium algorithm is to find a balance state when the strategies of multiple participants (which can be regarded as the demand for physical performance and sustained-release performance of the drug) influence each other, so that no party can obtain better results by changing the strategy alone, and the relationship between physical performance and sustained-release performance of the drug and their impact on the performance of the final product are comprehensively considered. For example, the following may happen: if the first temperature control strategy is over-adjusted in pursuit of better physical properties, it may have an adverse effect on the sustained-release performance of the drug; vice versa, the two temperature control strategies are constantly adjusted and balanced, various possible combinations and adjustment methods are tried, and the degree of realization of physical properties and sustained-release performance of the drug under each possible strategy combination is evaluated, and compared and weighed with the control performance reset coefficient. After many calculations and comparisons, the algorithm will eventually find an optimal strategy combination, so that while meeting the requirements of the control performance reset coefficient, both physical properties and sustained-release performance of the drug can reach a relatively balanced and optimized state. This optimal strategy combination is the final production line temperature control strategy.

[0036] In a possible implementation, based on the control performance reset coefficient, the first temperature control strategy and the second temperature control strategy are balanced and optimized using the Nash equilibrium algorithm to obtain the production line temperature control strategy. Step S600 further includes step S610, constructing a balanced evaluation function based on the control performance reset coefficient. Specifically, the control performance reset coefficient is an important parameter determined based on a series of operations such as the analysis, adjustment and redistribution of the performance response variables in the early stage, reflecting the relative importance and weight of different performances in the overall control target, and constructing a balanced evaluation function. The purpose of the function is to comprehensively consider the relationship between physical properties and drug sustained-release performance and temperature, temperature execution time, and to accurately measure the impact of different temperature control strategies on these two properties. Taking physical properties as an example, determine the temperature ( ) The optimal temperature corresponding to the physical performance target requirements ( ), and the temperature execution time ( ) The optimal temperature execution time corresponding to the physical performance target requirements ( ) is calculated by introducing the loss cost of temperature for physical properties ( ) and the weight of the temperature execution time on the loss of physical performance ( ), converting the difference into a specific loss value. The weight is derived from experience, experimental data or theoretical analysis, and is used to indicate the degree of performance loss caused by the unit difference. For the sustained-release performance of the drug, a similar method is used to determine the temperature ( ) The optimal temperature corresponding to the target demand of sustained-release performance of the drug ( ), and the temperature execution time ( ) The optimal temperature execution time corresponding to the target demand of sustained-release performance of the drug ( ) and multiply it by the corresponding loss cost weight ( and ), and finally, the relevant parts of the physical properties and the sustained-release properties of the drug are combined and multiplied by their respective control performance reset coefficients ( and ), a balanced evaluation function was constructed that can comprehensively evaluate the impact of temperature control strategies on physical properties and sustained-release performance of pharmaceuticals. The balanced evaluation function can fully reflect the importance represented by the control performance reset coefficient, as well as the specific impact of factors such as temperature and temperature execution time on different performances, providing a powerful tool for subsequent strategy evaluation and optimization.

[0037] Step S620, using the equilibrium evaluation function to perform equilibrium identification on the first temperature control strategy and the second temperature control strategy. Specifically, obtain the specific parameters of the first temperature control strategy and the second temperature control strategy, including the corresponding temperature value and temperature execution time, substitute the temperature and temperature execution time values ​​in the first temperature control strategy into the equilibrium evaluation function, and calculate various differences related to physical properties and sustained-release properties of the drug, for example, calculate the difference between the temperature and the optimal temperature corresponding to the physical performance target requirement, and the difference between the temperature execution time and the optimal temperature execution time corresponding to the physical performance target requirement. Next, these differences are multiplied by their respective corresponding loss cost weights and by the corresponding reset coefficients to obtain the evaluation results for physical properties and sustained-release performance of pharmaceuticals under the first temperature control strategy. The temperature and temperature execution time values ​​in the second temperature control strategy are substituted into the equilibrium evaluation function, and the same calculation steps are performed to obtain the evaluation results under the second temperature control strategy. During the calculation process, the performance of the two strategies in terms of physical properties and sustained-release performance of pharmaceuticals is compared and analyzed, and the size of each difference and their impact on the final evaluation results are observed. By comparing the evaluation results of the two strategies, it is determined which strategy is closer to the equilibrium state when comprehensively considering the physical properties and sustained-release performance of pharmaceuticals.

[0038] Step S630, when the equilibrium convergence target is reached, the production line temperature control strategy is output. Specifically, in the process of evaluating and comparing the first temperature control strategy and the second temperature control strategy using the equilibrium evaluation function, the changes in the evaluation results will be continuously monitored, and the temperature control strategy will be continuously adjusted and optimized, and its performance in the equilibrium evaluation function will be recalculated, and the output value of the evaluation function will be observed. After calculation and adjustment, it is found that no matter how the temperature control strategy is changed, the output value of the evaluation function will no longer change significantly, or its change is already within the pre-set acceptable range. It is considered that the equilibrium convergence target has been reached. Reaching the equilibrium convergence target means that the current temperature control strategy has reached a relatively optimal balance between physical properties and sustained-release performance of the drug, and the current positive Among the multiple temperature control strategies evaluated and compared, the strategy with the best performance in the equilibrium evaluation function is selected, that is, the strategy that can better meet both physical properties and drug sustained-release properties and minimize overall losses. The selected temperature control strategy is determined as the final production line temperature control strategy, and it is output in a clear and concise manner, including the specific parameters of the temperature control strategy, such as temperature setting value, temperature execution time, etc., in the form of reports, data files or direct transmission to the production control system. The output production line temperature control strategy will serve as the basis for controlling the temperature in the actual production process to ensure that the products produced can meet the expected goals and requirements in terms of physical properties and drug sustained-release properties.

[0039] Step S640, wherein the expression of the equilibrium evaluation function is: , T is temperature, t is temperature execution time, is the loss cost of temperature on physical properties, is the weight of the loss of physical performance due to temperature execution time, is the loss cost weight of temperature on the sustained release performance of the drug, is the loss cost weight of temperature execution time on the sustained release performance of the drug, and They are the reset coefficients of physical properties and sustained-release performance of pharmaceuticals, The optimal temperature corresponding to the physical performance target requirements, Optimal temperature execution time corresponding to physical performance target requirements, The optimal temperature corresponding to the target demand of sustained-release performance of the drug, is the optimal temperature execution time corresponding to the target requirement of sustained-release performance of the drug. Specifically, the function To comprehensively evaluate the temperature ( ) and temperature execution time ( ) has an impact on the overall performance, and for the physical properties middle, It represents the weight of the loss cost of temperature for physical properties, reflecting the relative importance of the loss caused by temperature deviation to physical properties. ) Deviates from the optimal temperature corresponding to the physical performance target requirements hour, Calculate the square of this temperature deviation and multiply it by the weight The latter indicates the loss caused by temperature deviation. is the weight of the loss of temperature execution time for physical performance, Calculate the square of the temperature execution time deviation and multiply it by the weight The latter represents the physical performance loss caused by the temperature execution time deviation. The two parts are added and then multiplied by the reset coefficient , in order to reflect the weight of physical properties in the overall evaluation, for the sustained-release performance of the drug, The principle is similar to Reflects the weight of the impact of temperature deviation on the loss of sustained-release performance of the drug, Reflects the weight of the impact of temperature execution time deviation on the loss of sustained-release performance of the drug, Calculate the square of the deviation of temperature and temperature execution time respectively, multiply by the corresponding weight, add them together, and then multiply by the reset coefficient , highlighting the importance of sustained-release performance of pharmaceuticals in the overall evaluation. In practical applications, the specific temperature value, temperature execution time value, various weights, optimal temperature, and optimal temperature execution time value are substituted into the function for calculation. Through the calculation results, the performance of the current temperature control strategy in satisfying physical properties and sustained-release performance of pharmaceuticals can be quantitatively evaluated. Smaller function values ​​indicate a temperature control strategy that is closer to the ideal and can achieve a better balance between physical properties and sustained-release performance of pharmaceuticals. Larger function values ​​indicate that the temperature and temperature execution time need to be further adjusted to optimize the control strategy. The balanced evaluation function provides an accurate and effective mathematical model for evaluating and optimizing the temperature control strategy by comprehensively considering the relevant parameters of temperature, temperature execution time, physical properties, and sustained-release performance of pharmaceuticals.

[0040] In a possible implementation, step S710 is included to determine the type state in the control performance target, and when the control performance target only includes the sustained-release performance of the drug, obtain the influence function relationship between the performance response variable of the sustained-release performance of the drug and the temperature. Specifically, the type state in the control performance target is determined. If the control performance target only includes the sustained-release performance of the drug, the influence function relationship between the performance response variable of the sustained-release performance of the drug and the temperature needs to be determined through preliminary experimental research or theoretical analysis, for example, clarifying how the performance response variables such as the concentration of certain drug components and the properties of the carrier material affect the sustained-release effect of the drug as the temperature changes.

[0041] Step S720, fitting the drug release curve under different performance response variables according to the historical experimental data. Specifically, fitting the drug release curve under different performance response variables according to the historical experimental data, the historical experimental data includes the drug release observed under various experimental conditions (different performance response variable combinations), and the data is processed and fitted by mathematical methods to obtain a curve model that can describe the change of drug release over time.

[0042] Step S730, traverse and match the drug release curve according to the target demand to obtain a target release curve. Specifically, traverse and match the fitted drug release curve according to the specific target demand (such as the expected drug release rate, total release amount, etc.), and select the curve that best meets the target demand from among the numerous curves, i.e., the target release curve.

[0043] Step S740, using the influence function relationship to perform temperature control corresponding analysis on the target release curve, and obtain the production line temperature control strategy. Specifically, using the influence function relationship between the performance response variable and the temperature obtained previously, the target release curve is analyzed for temperature control corresponding analysis, and the temperature control conditions required to achieve the sustained-release performance of the drug represented by the target release curve are analyzed, and finally the production line temperature control strategy that can meet the control performance target is determined. The solution goes through a series of targeted analysis and processing steps, from judging the control performance target, to obtaining the key function relationship and curve, and then to finally analyzing the temperature control strategy, to ensure that the production control target can be effectively achieved only for the sustained-release performance of the drug.

[0044] In a possible implementation, after determining the type state in the control performance target, it also includes: step S750, when the control performance target only includes physical performance, based on historical experimental data, an impact comparison analysis is performed on the adjustment impact relationship between the control performance target and the temperature to obtain a synergistic impact relationship and a synergistic impact coefficient, the synergistic impact relationship is used to characterize the mutual influence state between the control performances during temperature adjustment, including a conflict relationship and a promotion relationship, the conflict relationship being that the two control performances are in opposite directions in the temperature adjustment, and the promotion relationship being that the two control performances are in the same direction in the temperature adjustment. Specifically, when the control performance objectives only include physical properties, based on historical experimental data, data related to the control performance objectives (such as strength, softness, breathability, etc.) and temperature adjustment are extracted from a large number of past experiments, and the data are compared and analyzed to observe the responses of different physical properties when the temperature changes, and to determine the synergistic influence relationship between the physical properties. If one physical property improves with increasing temperature, while the other physical property deteriorates with increasing temperature, it is a conflicting relationship. If both physical properties improve with increasing temperature or both get better with decreasing temperature, it is a promoting relationship. The synergistic influence coefficient is calculated to quantitatively describe the degree of this mutual influence.

[0045] Step S760, obtaining the temperature constraint threshold of each control performance target. Specifically, the temperature constraint threshold of each control performance target is determined based on the design requirements of the product, the characteristics of the material or the relevant industry standards. For example, the strength of a certain material will drop sharply when exceeding a specific temperature, so the temperature is the constraint threshold of the control performance of strength.

[0046] Step S770, construct an evaluation function based on the synergistic influence relationship and the synergistic influence coefficient, use the temperature constraint threshold as a constraint condition, and establish a temperature control optimization model. Specifically, based on the determined synergistic influence relationship and synergistic influence coefficient, construct an evaluation function, the evaluation function is used to comprehensively evaluate the overall performance of physical properties under different temperature conditions, use the previously obtained temperature constraint threshold as a constraint condition, and establish a temperature control optimization model together with the evaluation function.

[0047] Step S780, use the temperature control optimization model to perform iterative optimization of temperature control, and obtain the production line temperature control strategy when the optimization target is reached. Specifically, use the temperature control optimization model to perform iterative optimization of temperature control. In each iteration, adjust the temperature value and calculate the result of the evaluation function. At the same time, check whether the temperature constraint threshold is met. If not, continue to adjust the temperature for the next round of iterations. If it is met, further determine whether the optimization target has been achieved, such as whether a temperature value that makes the evaluation function optimal or meets specific accuracy requirements has been found. When the optimization target is reached, the temperature value and related control conditions determined at this time are the final production line temperature control strategy. The strategy can achieve optimal temperature control while only considering physical properties to meet the physical performance requirements of the product. The solution determines the most suitable production line temperature control strategy for the control performance target that only includes physical properties through systematic analysis, modeling and optimization processes.

[0048] The embodiment of the present application adopts the method of obtaining target performances such as physical properties and sustained-release performance of non-woven fabrics, parsing relevant performance response variables and configuring proportion coefficients, identifying the correlation and determining the influence degree with cross-linking temperature and control time as targets, screening performance response variables that meet the threshold as control performance targets and resetting the proportion coefficients, and when the control performance targets include physical and sustained-release performances, using their response variables as optimization variables through the first and second temperature control strategies of the optimization algorithm, and then optimizing with the Nash equilibrium algorithm based on the reset coefficients to obtain the production line temperature control strategy, thereby achieving the technical effect of improving the overall quality and performance of the product and meeting the diversified market needs.

[0049] In the above, refer to Figure 1 The temperature control method for producing chitosan nonwoven fabric according to an embodiment of the present invention is described in detail. Figure 2 A temperature control device for producing chitosan nonwoven fabric according to an embodiment of the present invention is described.

[0050] The temperature control device for the production of chitosan non-woven fabrics according to the embodiment of the present invention is used to solve the technical problem that the existing temperature control requirements for the production of chitosan non-woven fabrics cannot be accurately and comprehensively balanced between the physical properties and the sustained-release performance of the drug, and cannot formulate a scientific, optimized, and adaptable temperature control strategy, so as to achieve the technical effect of improving the overall quality and performance of the product and meeting the diversified needs of the market. The temperature control device for the production of chitosan non-woven fabrics includes: a target performance acquisition module 10, a proportion coefficient configuration module 20, a temperature control influence determination module 30, a coefficient reset module 40, a control strategy acquisition module 50, and a production line temperature control strategy acquisition module 60.

[0051] The target performance acquisition module 10 is used to obtain the target performance of the non-woven fabric, including physical properties and drug sustained-release performance;

[0052] The proportion coefficient configuration module 20 is used to analyze the performance response variables based on the target requirements of the physical properties and the sustained-release performance of the pharmaceutical agent, wherein the performance response variables are descriptive parameter variables related to the physical properties and the sustained-release performance of the pharmaceutical agent, and configure the proportion coefficient of each performance response variable according to the target requirements;

[0053] The temperature control influence determination module 30 is used to identify the correlation of the performance response variables and determine the temperature control influence with the cross-linking temperature and the temperature control time as the target;

[0054] The coefficient reset module 40 is used to select the performance response variable whose temperature control influence meets the threshold as the control performance target, and reset the proportion based on the proportion coefficient to obtain the control performance reset coefficient;

[0055] The control strategy acquisition module 50 is used to obtain a first temperature control strategy and a second temperature control strategy by an optimization algorithm when the control performance target includes the physical performance and the sustained-release performance of the drug, respectively using the performance response variables of the physical performance and the sustained-release performance of the drug as optimization variables, wherein the first temperature control strategy corresponds to the physical performance and the second temperature control strategy corresponds to the sustained-release performance of the drug;

[0056] The production line temperature control strategy acquisition module 60 is used to optimize the first temperature control strategy and the second temperature control strategy based on the control performance reset coefficient using the Nash equilibrium algorithm to obtain the production line temperature control strategy.

[0057] The specific configuration of the target performance acquisition module 10 will be described in detail below. As described above, the target performance of the non-woven fabric is obtained, including physical properties and drug sustained-release performance. The target performance acquisition module 10 may further include: a user performance requirement acquisition unit for obtaining user performance requirements; a performance index setting unit for setting performance indicators according to the physical properties and drug sustained-release performance; a feature vector determination unit for constructing cluster features according to the performance indicators, and performing feature analysis on the user performance requirements to determine the user requirement feature vector; a non-woven fabric target performance construction unit for clustering the user requirement feature vector with the cluster features, obtaining the target features of the physical properties and the target features of the drug sustained-release performance, and constructing the non-woven fabric target performance.

[0058] The specific configuration of the proportion coefficient configuration module 20 will be described in detail below. As described above, based on the target requirements of the physical properties and the sustained-release performance of the drug, the performance response variables are parsed, and the performance response variables are descriptive parameter variables related to the physical properties and the sustained-release performance of the drug, and the proportion coefficients of each performance response variable are configured according to the target requirements. The proportion coefficient configuration module 20 may further include: a target requirement quantification unit is used to determine the target requirements according to the user performance requirements and quantify the target requirements; an impact adjustment coefficient determination unit is used to match and analyze the historical experimental data based on the quantitative requirements of the target requirements, and determine the constraint proportion and impact adjustment coefficient of the performance response variable; the proportion coefficient determination unit is used to use the constraint proportion as the basic proportion relationship, and allocate the proportion according to the quantitative requirements of the target requirements according to the impact adjustment coefficient, and determine the proportion coefficient, which is the weighted result of the basic proportion and the allocated proportion.

[0059] The specific configuration of the coefficient reset module 40 will be described in detail below. As described above, the performance response variable whose temperature control influence meets the threshold is screened as the control performance target, and the proportion is reset based on the proportion coefficient to obtain the control performance reset coefficient. The coefficient reset module 40 may further include: a difference adjustment performance variable positioning unit for performing difference matching on the performance response variable according to the control performance target and locating the difference adjustment performance variable; an adjustment proportion extraction unit for extracting the adjustment proportion when the difference adjustment performance variable exists; a proportional relationship calculation unit for obtaining the proportion coefficient of the control performance target and calculating the proportional relationship using the proportion coefficient; an allocation proportion acquisition unit for redistributing the adjustment proportion using the proportion relationship to obtain the redistributed proportion; and a reset coefficient acquisition unit for superimposing the proportion coefficient of the control performance target with the redistributed proportion to obtain the control performance reset coefficient.

[0060] The specific configuration of the production line temperature control strategy acquisition module 60 will be described in detail below. As described above, based on the control performance reset coefficient, the Nash equilibrium algorithm is used to balance and optimize the first temperature control strategy and the second temperature control strategy to obtain the production line temperature control strategy. The production line temperature control strategy acquisition module 60 may further include: a balanced evaluation function construction unit for constructing a balanced evaluation function based on the control performance reset coefficient; a balanced identification unit for using the balanced evaluation function to balance the first temperature control strategy and the second temperature control strategy; a production line temperature control strategy output unit for outputting the production line temperature control strategy when the balanced convergence target is reached; a balanced evaluation function unit for wherein the expression of the balanced evaluation function is: , T is temperature, t is temperature execution time, is the loss cost of temperature on physical properties, is the weight of the loss of physical performance due to temperature execution time, is the loss cost weight of temperature on the sustained release performance of the drug, is the loss cost weight of temperature execution time on the sustained release performance of the drug, and They are the reset coefficients of physical properties and sustained-release performance of pharmaceuticals, The optimal temperature corresponding to the physical performance target requirements, Optimal temperature execution time corresponding to physical performance target requirements, The optimal temperature corresponding to the target demand of sustained-release performance of the drug, It is the optimal temperature execution time corresponding to the target requirement of sustained-release performance of the drug.

[0061] The device further includes: an influence function relationship unit for judging the type state in the control performance target, and when the control performance target only includes the sustained-release performance of the drug, obtaining the influence function relationship between the performance response variable of the sustained-release performance of the drug and the temperature; a drug release curve unit for fitting the drug release curve under different performance response variables according to historical experimental data; and a production line temperature control strategy acquisition unit for performing temperature control corresponding analysis on the target release curve using the influence function relationship to obtain the production line temperature control strategy.

[0062] The device further includes: a synergistic influence coefficient unit for performing an influence comparison analysis on the adjustment influence relationship between the control performance target and the temperature based on historical experimental data when the control performance target only includes physical performance, and obtaining a synergistic influence relationship and a synergistic influence coefficient. The synergistic influence relationship is used to characterize the mutual influence state between the control performances in temperature adjustment, including a conflict relationship and a promotion relationship. The conflict relationship means that the two control performances are in opposite directions in temperature adjustment, and the promotion relationship means that the two control performances are in the same direction in temperature adjustment; a temperature constraint threshold unit is used to obtain the temperature constraint threshold of each control performance target; a temperature control optimization model establishment unit is used to construct an evaluation function based on the synergistic influence relationship and the synergistic influence coefficient, and to establish a temperature control optimization model by taking the temperature constraint threshold as a constraint condition; an iterative optimization unit is used to perform iterative optimization of temperature control using the temperature control optimization model, and to obtain the production line temperature control strategy when the optimization target is reached.

[0063] The temperature control device for the production of chitosan non-woven fabrics provided in the embodiment of the present invention can execute the temperature control method for the production of chitosan non-woven fabrics provided in any embodiment of the present invention, and has the corresponding functional modules and beneficial effects of the execution method.

[0064] Although the present application makes various references to certain modules in the device according to the embodiments of the present application, any number of different modules may be used and run on the user terminal and / or server, and the various units and modules included are only divided according to functional logic, but are not limited to the above division, as long as the corresponding functions can be achieved; in addition, the specific names of the functional units are only for the convenience of distinguishing each other, and are not used to limit the scope of protection of the present invention.

[0065] The above specific implementation manner does not constitute a limitation to the protection scope of the present application. It should be understood by those skilled in the art that various modifications, combinations and substitutions can be made according to design requirements and other factors. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present application should be included in the protection scope of the present application. In some cases, the actions or steps recorded in the present application can be performed in an order different from that in the embodiment and can still achieve the desired results. In addition, the process depicted in the accompanying drawings does not necessarily require the specific order or continuous order shown to achieve the desired results. In some embodiments, multitasking and parallel processing are also possible or may be advantageous.

Claims

1. A temperature control method for producing chitosan nonwoven fabrics, characterized in that: The temperature control method for producing chitosan nonwoven fabrics comprises: Obtain the target properties of nonwoven fabrics, including physical properties and drug sustained-release properties; Based on the target requirements of the physical properties and sustained-release performance of the pharmaceutical agent, the performance response variables are analyzed, where the performance response variables are descriptive parameter variables related to the physical properties and sustained-release performance of the pharmaceutical agent, and the proportion coefficients of the performance response variables are configured according to the target requirements; Taking cross-linking temperature and temperature control time as targets, identifying the correlation of the performance response variables and determining the influence of temperature control; The performance response variable whose temperature control influence satisfies a threshold is selected as a control performance target, and the proportion is reset based on the proportion coefficient to obtain the control performance reset coefficient; When the control performance target includes the physical property and the sustained-release performance of the drug, the performance response variables of the physical property and the sustained-release performance of the drug are respectively used as optimization variables, and a first temperature control strategy and a second temperature control strategy are obtained through an optimization algorithm, wherein the first temperature control strategy corresponds to the physical property, and the second temperature control strategy corresponds to the sustained-release performance of the drug; Based on the control performance reset coefficient, the first temperature control strategy and the second temperature control strategy are balanced and optimized using a Nash equilibrium algorithm to obtain a production line temperature control strategy; Wherein, based on the control performance reset coefficient, the first temperature control strategy and the second temperature control strategy are balanced and optimized using the Nash equilibrium algorithm to obtain the production line temperature control strategy, including: Constructing a balanced evaluation function based on the control performance reset coefficient; Using the balanced evaluation function to perform balanced identification on the first temperature control strategy and the second temperature control strategy; When the equilibrium convergence target is reached, the production line temperature control strategy is output; Wherein, the expression of the equilibrium evaluation function is: , T is temperature, t is temperature execution time, is the loss cost of temperature on physical properties, is the weight of the loss of physical performance due to temperature execution time, is the loss cost weight of temperature on the sustained release performance of the drug, is the loss cost weight of temperature execution time on the sustained release performance of the drug, and They are the reset coefficients of physical properties and sustained-release performance of pharmaceuticals, The optimal temperature corresponding to the physical performance target requirements, Optimal temperature execution time corresponding to physical performance target requirements, The optimal temperature corresponding to the target demand of sustained-release performance of the drug, It is the optimal temperature execution time corresponding to the target requirement of sustained-release performance of the drug.

2. The temperature control method for producing chitosan nonwoven fabrics according to claim 1, characterized in that: The target properties of the nonwoven fabric, including physical properties and sustained-release properties of the drug, are obtained, including: Obtain user performance requirements; Setting performance indicators according to the physical properties and sustained-release properties of the drug; Constructing cluster features according to the performance indicators, and performing feature analysis on the user performance requirements to determine a user requirement feature vector; The user demand feature vector and the clustering feature are used to perform clustering, the target features of the physical properties and the target features of the sustained-release performance of the drug are obtained, and the target performance of the non-woven fabric is constructed.

3. The temperature control method for producing chitosan nonwoven fabrics according to claim 2, characterized in that: The configuring the proportion coefficient of each performance response variable according to the target demand includes: Determine the target requirement according to the user performance requirement, and quantify the target requirement; Based on the quantitative requirements of the target demand, the constraint proportion and impact adjustment coefficient of the performance response variable are determined by matching and analyzing the historical experimental data; The constraint proportion is used as the basic proportion relationship, and the proportion is allocated according to the quantitative requirements of the target demand based on the impact adjustment coefficient to determine the proportion coefficient, which is a weighted result of the basic proportion and the allocated proportion.

4. The temperature control method for producing chitosan nonwoven fabrics according to claim 1, characterized in that: The resetting the proportion based on the proportion coefficient to obtain the control performance reset coefficient includes: Performing difference matching on the performance response variables according to the control performance target, and locating the difference to adjust the performance variables; When the difference adjustment performance variable exists, extracting the adjustment proportion; Obtaining a proportion coefficient of the control performance target, and calculating a proportional relationship using the proportion coefficient; Redistributing the adjusted proportion by using the proportional relationship to obtain a redistributed proportion; The control performance reset coefficient is obtained by superimposing the proportion coefficient of the control performance target and the redistribution proportion.

5. The temperature control method for producing chitosan nonwoven fabrics according to claim 1, characterized in that: The performance response variable whose temperature control influence meets a threshold is selected as a control performance target, and then the following steps are further included: Determining the type state of the control performance target, and when the control performance target only includes the sustained-release performance of the pharmaceutical agent, obtaining the influence function relationship between the performance response variable of the sustained-release performance of the pharmaceutical agent and the temperature; Fitting the drug release curves under different performance response variables based on historical experimental data; Traversing and matching the drug release curve according to the target demand to obtain a target release curve; The temperature control corresponding analysis of the target release curve is performed using the influence function relationship to obtain the production line temperature control strategy.

6. The temperature control method for producing chitosan nonwoven fabrics according to claim 5, characterized in that: Determining the type status of the control performance target, and then further comprising: When the control performance target only includes physical performance, an influence comparison analysis is performed on the adjustment influence relationship between the control performance target and the temperature based on historical experimental data to obtain a synergistic influence relationship and a synergistic influence coefficient. The synergistic influence relationship is used to characterize the mutual influence state between the control performances in the temperature adjustment, including a conflict relationship and a promotion relationship. The conflict relationship means that the directions of the two control performances in the temperature adjustment are opposite, and the promotion relationship means that the directions of the two control performances in the temperature adjustment are the same; Obtaining temperature constraint thresholds for each control performance target; An evaluation function is constructed based on the synergistic influence relationship and the synergistic influence coefficient, and a temperature control optimization model is established by taking the temperature constraint threshold as a constraint condition; The temperature control optimization model is used to perform iterative optimization of temperature control, and when the optimization target is reached, the production line temperature control strategy is obtained.

7. A temperature control device for the production of chitosan nonwoven fabrics, characterized in that: The device is used to implement the temperature control method for producing chitosan non-woven fabrics according to any one of claims 1 to 6, and the device comprises: A target performance acquisition module, which is used to obtain target performance of the non-woven fabric, including physical properties and drug sustained-release performance; A proportion coefficient configuration module, which is used to analyze performance response variables based on the target requirements of the physical properties and the sustained-release performance of the pharmaceutical agent, wherein the performance response variables are descriptive parameter variables related to the physical properties and the sustained-release performance of the pharmaceutical agent, and configure the proportion coefficient of each performance response variable according to the target requirements; A temperature control influence determination module, the temperature control influence determination module is used to identify the correlation of the performance response variables and determine the temperature control influence with the cross-linking temperature and the temperature control time as targets; A coefficient reset module, the coefficient reset module is used to select the performance response variable whose temperature control influence meets the threshold as the control performance target, and reset the proportion based on the proportion coefficient to obtain the control performance reset coefficient; A control strategy acquisition module, wherein when the control performance target includes the physical property and the sustained-release performance of the drug, the control strategy acquisition module is used to respectively use the performance response variables of the physical property and the sustained-release performance of the drug as optimization variables, and obtain a first temperature control strategy and a second temperature control strategy through an optimization algorithm, wherein the first temperature control strategy corresponds to the physical property, and the second temperature control strategy corresponds to the sustained-release performance of the drug; A production line temperature control strategy acquisition module is used to optimize the first temperature control strategy and the second temperature control strategy based on the control performance reset coefficient using a Nash equilibrium algorithm to obtain a production line temperature control strategy.